Carillon Tower Advisers’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$67.9M Buy
354,554
+143,171
+68% +$26M 0.41% 74
2020
Q3
$31.2M Sell
211,383
-50,065
-19% -$7.16M 0.42% 67
2020
Q2
$32.3M Sell
261,448
-79,297
-23% -$9.33M 0.25% 128
2020
Q1
$32.1M Hold
340,745
0.32% 112
2019
Q4
$31.5M Hold
340,745
0.21% 168
2019
Q3
$26.1M Hold
340,745
0.18% 199
2019
Q2
$29.3M Buy
+340,745
New +$23.2M 0.2% 185

Other funds holding RGEN

Carillon Tower Advisers's RGEN Position: Q4 2020 in Review

Carillon Tower Advisers increased its Repligen (RGEN) stake by 68% in Q4 2020, buying an estimated $26M and bringing the position to 354,554 shares worth $67.9M. The position accounts for 0.41% of the portfolio, ranked #74.

Carillon Tower Advisers first reported a position in RGEN in Q2 2019 and has held it in 7 quarters since. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

  • Carillon Tower Advisers held 354,554 shares of Repligen worth $67.9M as of Q4 2020.
  • Carillon Tower Advisers bought 143,171 Repligen shares in Q4 2020, an estimated $26M.
  • Repligen made up 0.41% of Carillon Tower Advisers's portfolio in Q4 2020, its #74 holding.
  • Carillon Tower Advisers first reported a position in Repligen in Q2 2019 and has held it in 7 quarters since.
  • 449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.